Optimized to drive a wide range of magnetron models with peak RF power of up to 2 MW, the M060 is engineered for adaptability across diverse environments. The modulator leverages cutting-edge ...
Using a bioelectronic device to deliver pulsed electricity to the body has proven to be a promising strategy to treat drug-resistant hypertension patients, according to Penn State researcher Tao ...
Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...